Cargando…
Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema
Siponimod is a sphingosine-1-phosphate receptor modulator used as disease-modifying therapy for relapsing-remitting multiple sclerosis similar to Fingolimod which has been known to cause dose dependent fingolimod associated macular oedema (FAME). We report a case of delayed onset bilateral cystoid m...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660509/ https://www.ncbi.nlm.nih.gov/pubmed/36368737 http://dx.doi.org/10.1136/bcr-2022-251066 |
_version_ | 1784830414731345920 |
---|---|
author | Foos, William F Culp, Catherine Asahi, Masumi Patronas, Marena |
author_facet | Foos, William F Culp, Catherine Asahi, Masumi Patronas, Marena |
author_sort | Foos, William F |
collection | PubMed |
description | Siponimod is a sphingosine-1-phosphate receptor modulator used as disease-modifying therapy for relapsing-remitting multiple sclerosis similar to Fingolimod which has been known to cause dose dependent fingolimod associated macular oedema (FAME). We report a case of delayed onset bilateral cystoid macular oedema in a patient with stable proliferative diabetic retinopathy who developed cystoid macular oedema in the setting of siponimod (Mayzent; Novartis Pharmaceuticals; Cambridge, Massachusetts, USA) use. As with FAME, cystoid macular oedema resolved in the patient’s eyes with drug cessation and adjunctive topical anti-inflammatory therapy. We highlight unique fluorescein angiographic findings within this class of drugs as well as the clinical challenge posed by comorbid diabetic and inflammatory ophthalmic pathology. |
format | Online Article Text |
id | pubmed-9660509 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96605092022-11-15 Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema Foos, William F Culp, Catherine Asahi, Masumi Patronas, Marena BMJ Case Rep Case Reports: Adverse drug reactions and complications Siponimod is a sphingosine-1-phosphate receptor modulator used as disease-modifying therapy for relapsing-remitting multiple sclerosis similar to Fingolimod which has been known to cause dose dependent fingolimod associated macular oedema (FAME). We report a case of delayed onset bilateral cystoid macular oedema in a patient with stable proliferative diabetic retinopathy who developed cystoid macular oedema in the setting of siponimod (Mayzent; Novartis Pharmaceuticals; Cambridge, Massachusetts, USA) use. As with FAME, cystoid macular oedema resolved in the patient’s eyes with drug cessation and adjunctive topical anti-inflammatory therapy. We highlight unique fluorescein angiographic findings within this class of drugs as well as the clinical challenge posed by comorbid diabetic and inflammatory ophthalmic pathology. BMJ Publishing Group 2022-11-11 /pmc/articles/PMC9660509/ /pubmed/36368737 http://dx.doi.org/10.1136/bcr-2022-251066 Text en © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Reports: Adverse drug reactions and complications Foos, William F Culp, Catherine Asahi, Masumi Patronas, Marena Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
title | Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
title_full | Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
title_fullStr | Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
title_full_unstemmed | Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
title_short | Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
title_sort | siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema |
topic | Case Reports: Adverse drug reactions and complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660509/ https://www.ncbi.nlm.nih.gov/pubmed/36368737 http://dx.doi.org/10.1136/bcr-2022-251066 |
work_keys_str_mv | AT fooswilliamf siponimodrelatedbilateralcystoidmacularoedemaandintravenousfluoresceinangiographicfindingsinapatientwithstableproliferativediabeticretinopathywithouthistoryofdiabeticmacularoedema AT culpcatherine siponimodrelatedbilateralcystoidmacularoedemaandintravenousfluoresceinangiographicfindingsinapatientwithstableproliferativediabeticretinopathywithouthistoryofdiabeticmacularoedema AT asahimasumi siponimodrelatedbilateralcystoidmacularoedemaandintravenousfluoresceinangiographicfindingsinapatientwithstableproliferativediabeticretinopathywithouthistoryofdiabeticmacularoedema AT patronasmarena siponimodrelatedbilateralcystoidmacularoedemaandintravenousfluoresceinangiographicfindingsinapatientwithstableproliferativediabeticretinopathywithouthistoryofdiabeticmacularoedema |